Browse News
Filter News
Found 6 articles
-
Sigyn Therapeutics Appoints Donald J. Hillebrand, M.D. to its Scientific Advisory Board
4/26/2022
Sigyn Therapeutics, Inc. today announced the appointment of Donald J. Hillebrand,M.D. to its Scientific Advisory Board.
-
Sigyn Therapeutics Appoints Ajay Verma, M.D., Ph.D. to its Scientific Advisory Board
3/31/2022
Sigyn Therapeutics, Inc. today announced the appointment of Ajay Verma, M.D., Ph.D.to its Scientific Advisory Board.
-
Sigyn Therapeutics Announces Filing of 2021 Annual Report on Form 10-K
3/22/2022
Sigyn Therapeutics, Inc. announced that it has filed its annual report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Commission and provided a corporate update.
-
BioSpace Movers & Shakers, March 4
3/4/2022
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
A Perfect Storm of Superbugs
1/17/2022
To alleviate the problem of antibiotic-resistant bacteria, or superbugs, several biotechnology companies are developing different strategies to target and kill these microorganisms. -
Sigyn is not only trying to treat the inflammatory mediators that fuel sepsis; it wants to prevent the life-threatening event from occurring altogether.